The Magtrace® lymphatic tracer from @endomag enables more flexible sentinel lymph node biopsies. A simple solution for breast cancer staging.

Cambridge, England
Joined February 2018
Have you seen the SentimagIC non-inferiority trial results? The paper demonstrates that @MagtraceSurgery is a viable non-radioactive alternative to Technetium-99m and Blue Dye for axillary SLN detection in early-stage breast cancer. ➡️ PubMed link here: ncbi.nlm.nih.gov/pubmed/3129…
3
14
1
31
Why adopt #Magtrace as your new non-radioactive tracer for SLNB? Here's an article from @UHhospitals and @DrJDietz who explain how our technologies have enabled better, more personalized care for women with breast cancer. 📰 uhhospitals.org/for-clinicia… #breastcancer #bcsm #bccww
7
12
We're here to improve axillary staging for #breastcancer. – at Cambridge, England
5
9
The future of axillary staging? Pilot results of the #MagUS study. No other lymphatic tracer can be used like this, opening up novel ways to approach axillary staging and minimise the impact on patients. #ABSConf18 #BreastCancer #PrecisionMedicine
1
8
10
Thank you to Prof Isabel Rubio for her presentation on SiennaXP, a lower volume-faster migrating version of Sienna+ for #SLNB. The interim results from her randomised trial are very promising, on par the SiennaXP detection rates in our US trial. #EBCC2018 #Magtrace #Sentimag